New Reports
•Report 6b: Provide subcategory info on chronic and acute on chronic
•Report 62: Log report: log of all cases producing a log error, must be run after report 62. Also, : CreateLog-allows creation of log file separately from running Report 62 to process faster when the case log information is not needed. This can cause
•Report 87c, 87d: Same as 87a, 87b without followup info
•Report 93: Treatments by age
•Report 94: Log of rejected cases
•Report 96: Call Type Detail to list the detail breakdown of the call type information for information calls
•Report arRptCus03: Special report
•Report c05: State and zip code for peds
•Report c04: Quick line review of cases
•Report c05: State and zip code for peds
•Report c06: Keycuts
Updated Reports
•Batch Reporting now has the capacity to retry five times to load
•Report(s): 2, 4, 6, 7, 9, 13, 23, 25, 31,32, 33, 34, 42, 45a, 45b, 45c, 46, 62, 63, 79,80,81 - General updates have been made.
•Report: 00 to compare county name as uppercase as well
•Reports 3 & 5 include error handling and annual subtotals.
•Report: 4 - Calculates row percentages
•Report: 6 - To accept and print non-rich text format information as well as Report 6 has been changed to 6a
•Report(s) 13, 21, 35, 36, 43, 44-Suppress rows if column is inactive and no data present
•Report 20: not display inactive decon row if no data present, corrected order of Other
•Report(s) 45a, 45b, 45c-added new codetypes
•Report(s) 52 changed to move code not captured to the bottom
•Report 54 – 58: Updates include pharaceutical and nonpharmaceutical subtotals at the end of the report, changes were made to move code not captured to the bottom,
•Report(s): 61, 61b: display number of substances label properly
•Report 62: Removed unknown column from Primary Center row and fixed ingestion and parenteral to not show a quantity.
•Report 63: Includes Syntax.
•Reports 68-69: Include pharmaceutical and nonpharmaceutical subtotals at end of report as well as report grouping. This enables a messages to be dis[played for specific product not selected (only generic).
•Report 73: Includes pharmaceutical and nonpharmaceutical subtotals at end of report
•Report(s) 79, 80, 81, 82: Added new scenarios, fixed printing first row of valid data and missing columns
•Report 84: Allow more room for full month name
•Report 94: Updated to search by status Rejected
•Report 95: Has become Report 95a and 95b
•Report 96: Includes Exposure calls and changed title to Call Subcategory
TOXICALL® Enhancements:
•Performance Enhancement: When opening cases, after the first case, open times can be significantly faster by using Windows memory more optimally. Our testing shows a case open time of approximately 8 seconds (on a slow Pentium 133 MHz) drops to 2 seconds when opening the second case and the first case window is closed. This assumes the scale case feature is turned off because cases are slower to open when the scaling must be performed.
•New: Added scale case option "Fast Open" to always open cases with scaling turned off. This will help minimize the amount of time required to open new cases.
•New: The user will now have a new button to scale the case once the case is open.
•New: Quick Case mode: This will allow you to view and edit cases on the screen while seeing a list of cases simultaneously. This mode is especially useful when you are managing multiple cases and need to quickly move between cases. If the case is not changed, you will not be prompted to save. When switching between cases, cases will be automatically quick saved, unless the case was previously saved as open or closed, in which case you will be prompted to save the case. This feature is also useful if you are reviewing cases.
•New: Created new views and reports to list system tables such as the Keycuts, SPI List, Generic Codes, Zip Codes, and Free Areas.
•Enhanced: Several reports have been updated to provide better reporting.
•Updated: The Autoupload process has been revised to provide a more stable Autoupload.
•Several other behind the scene enhancements have also been made to optimize TOXICALL® and prepare for other exciting new enhancement in the future.